Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2006 2
2007 4
2008 4
2009 7
2010 2
2011 5
2012 3
2013 3
2014 6
2015 7
2016 10
2017 7
2018 8
2019 14
2020 17
2021 17
2022 9
2023 14
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. Among authors: rivas jl. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
Palumbo A, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M, Spicka I, Hungria V, Munder M, Mateos MV, Mark TM, Qi M, Schecter J, Amin H, Qin X, Deraedt W, Ahmadi T, Spencer A, Sonneveld P; CASTOR Investigators. Palumbo A, et al. N Engl J Med. 2016 Aug 25;375(8):754-66. doi: 10.1056/NEJMoa1606038. N Engl J Med. 2016. PMID: 27557302 Free article. Clinical Trial.
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Rivas JL, Yndestad A, Connell CA, Szekanecz Z. Charles-Schoeman C, et al. Among authors: rivas jl. Ann Rheum Dis. 2023 Jan;82(1):119-129. doi: 10.1136/ard-2022-222259. Epub 2022 Sep 22. Ann Rheum Dis. 2023. PMID: 36137735 Free PMC article.
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance.
Kristensen LE, Danese S, Yndestad A, Wang C, Nagy E, Modesto I, Rivas J, Benda B. Kristensen LE, et al. Among authors: rivas j. Ann Rheum Dis. 2023 Jul;82(7):901-910. doi: 10.1136/ard-2022-223715. Epub 2023 Mar 17. Ann Rheum Dis. 2023. PMID: 36931693 Free PMC article. Clinical Trial.
The misfit mitral valve.
Mikulic SA, Rivas JR, Guo HJ, Esmail K. Mikulic SA, et al. Among authors: rivas jr. J Geriatr Cardiol. 2021 Oct 28;18(10):855-856. doi: 10.11909/j.issn.1671-5411.2021.10.008. J Geriatr Cardiol. 2021. PMID: 34754299 Free PMC article. No abstract available.
Versatile Mesoporous Nanoparticles for Cell Applications.
Seco Gudiña R, Yáñez Vilar S, González Gómez M, Vargas Osorio Z, de la Fuente M, Piñeiro Redondo Y, López R, Rivas J. Seco Gudiña R, et al. Among authors: rivas j. J Nanosci Nanotechnol. 2021 May 1;21(5):2824-2833. doi: 10.1166/jnn.2021.19054. J Nanosci Nanotechnol. 2021. PMID: 33653447
Magnetic nanoparticle-based hyperthermia for cancer treatment.
Bañobre-López M, Teijeiro A, Rivas J. Bañobre-López M, et al. Among authors: rivas j. Rep Pract Oncol Radiother. 2013 Nov 1;18(6):397-400. doi: 10.1016/j.rpor.2013.09.011. Rep Pract Oncol Radiother. 2013. PMID: 24416585 Free PMC article. Review.
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme.
Dougados M, Charles-Schoeman C, Szekanecz Z, Giles JT, Ytterberg SR, Bhatt DL, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Connell CA, Yndestad A, Rivas JL, Buch MH. Dougados M, et al. Among authors: rivas jl. Ann Rheum Dis. 2023 Apr;82(4):575-577. doi: 10.1136/ard-2022-223406. Epub 2023 Jan 31. Ann Rheum Dis. 2023. PMID: 36720582 Free PMC article. No abstract available.
Biomimetic magnetic silk scaffolds.
Samal SK, Dash M, Shelyakova T, Declercq HA, Uhlarz M, Bañobre-López M, Dubruel P, Cornelissen M, Herrmannsdörfer T, Rivas J, Padeletti G, De Smedt S, Braeckmans K, Kaplan DL, Dediu VA. Samal SK, et al. Among authors: rivas j. ACS Appl Mater Interfaces. 2015 Mar 25;7(11):6282-92. doi: 10.1021/acsami.5b00529. Epub 2015 Mar 10. ACS Appl Mater Interfaces. 2015. PMID: 25734962
124 results